AmorePacific TRPV1 antagonist

TRPV1 antagonist · Amorepacific Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AmorePacific TRPV1 antagonist, covering 2018-11-20 to 2018-11-20. Get the full timeline:

Most recent: Clinical Trial Update: CAPTAIN-AD: Clinical Study of AmorePacific's TRPV1 Antagonist in Atopic Dermatitis [Phase 3]